Centre for Molecular Medicine and Therapeutics, Vancouver, British Columbia, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
Genet Med. 2017 Dec;19(12):1300-1308. doi: 10.1038/gim.2017.50. Epub 2017 May 4.
PurposeWe analyzed the Exome Aggregation Consortium (ExAC) data set for the presence of individuals with pathogenic genotypes implicated in Mendelian pediatric disorders.MethodsClinVar likely/pathogenic variants supported by at least one peer-reviewed publication were assessed within the ExAC database to identify individuals expected to exhibit a childhood disorder based on concordance with disease inheritance modes: heterozygous (for dominant), homozygous (for recessive) or hemizygous (for X-linked recessive conditions). Variants from 924 genes reported to cause Mendelian childhood disorders were considered.ResultsWe identified ExAC individuals with candidate pathogenic genotypes for 190 previously published likely/pathogenic variants in 128 genes. After curation, we determined that 113 of the variants have sufficient support for pathogenicity and identified 1,717 ExAC individuals (~2.8% of the ExAC population) with corresponding possible/disease-associated genotypes implicated in rare Mendelian disorders, ranging from mild (e.g., due to SCN2A deficiency) to severe pediatric conditions (e.g., due to FGFR1 deficiency).ConclusionLarge-scale sequencing projects and data aggregation consortia provide unprecedented opportunities to determine the prevalence of pathogenic genotypes in unselected populations. This knowledge is crucial for understanding the penetrance of disease-associated variants, phenotypic variability, somatic mosaicism, as well as published literature curation for variant classification procedures and predicted clinical outcomes.
目的
我们分析了外显子组聚合联盟(ExAC)数据集,以确定存在与孟德尔儿科疾病相关的致病性基因型的个体。
方法
在 ExAC 数据库中评估了 ClinVar 中至少有一篇同行评议文献支持的可能/致病性变异体,以根据与疾病遗传模式的一致性来识别预期表现为儿童疾病的个体:杂合子(显性)、纯合子(隐性)或半合子(X 连锁隐性疾病)。考虑了报告可导致孟德尔儿童疾病的 924 个基因的变异体。
结果
我们在 128 个基因中发现了 190 个先前发表的可能/致病性变异体的 ExAC 个体,这些变异体具有候选致病性基因型。经过整理,我们确定了 113 个变异体具有足够的致病性支持,并确定了 1717 名 ExAC 个体(约占 ExAC 人群的 2.8%)具有与罕见孟德尔疾病相关的可能/疾病相关基因型,这些疾病的严重程度从轻度(例如,由于 SCN2A 缺乏)到严重的儿科疾病(例如,由于 FGFR1 缺乏)不等。
结论
大规模测序项目和数据聚合联盟为确定未选择人群中致病性基因型的患病率提供了前所未有的机会。这一知识对于理解疾病相关变异体的外显率、表型变异性、体细胞镶嵌性以及变异体分类程序和预测临床结果的已发表文献整理至关重要。